NuLens selected as a 2008 Technology Pioneer

Article

The World Economic Forum has selected 39 companies as Technology Pioneers for 2008 and NuLens is one of those honoured with this title.

The World Economic Forum has selected 39 companies as Technology Pioneers for 2008 and NuLens is one of those honoured with this title.

The Technology Pioneers were nominated by the world's leading technology experts, including venture capitalists, technology companies, academics and the media. The final selection from 273 nominees was made by a panel appointed by the World Economic Forum. Those selected are invited to participate in the World Economic annual meeting 2008 and in the Annual Meeting of the New Champions.

NuLens is currently developing a new accommodative intraocular lens (IOL) that is designed to enhance a patient's quality of vision following cataract surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.